NASDAQ: TCMDTactile Systems Technology Inc Stock
$12.41+0.03 (+0.24%)
Updated Aug 15, 2025
TCMD Price
$12.41
Fair Value Price
$19.74
Market Cap
$276.65M
52 Week Low
$8.61
52 Week High
$21.10
P/E
19.7x
P/B
1.42x
P/S
0.78x
PEG
61.28x
Dividend Yield
N/A
Revenue
$298.85M
Earnings
$15.11M
Gross Margin
74.7%
Operating Margin
7.9%
Profit Margin
5.1%
Debt to Equity
0.4
Operating Cash Flow
$42M
Beta
1.07
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
TCMD Overview
Tactile Systems Technology, Inc., a medical technology company, engages in the development and provision of medical devices for chronic diseases in the United States. The company offers Flexitouch Plus system, a pneumatic compression device for the treatment of lymphedema; Entre system, a portable pneumatic compression device that is used for the at-home treatment of venous disorders, such as lymphedema and chronic venous insufficiency, including venous leg ulcers; and AffloVest, a portable high frequency chest wall oscillation test for the treatment of retained pulmonary secretions such as bronchiectasis, cystic fibrosis, and various neuromuscular disorders. The company was incorporated in 1995 and is headquartered in Minneapolis, Minnesota.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine TCMD's potential to beat the market
BBuy
- Stocks with a Zen Rating of Buy (B) had an average return of +19.88% per year. Learn More
Zen Rating Component Grades
C
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Be the first to know about important TCMD news, forecast changes, insider trades & much more!
TCMD News
Overview
Due Diligence Score
–
Industry Average (27)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how TCMD scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
TCMD ($12.41) is undervalued by 37.14% relative to our estimate of its Fair Value price of $19.74 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety
Below Fair Value Valuation
TCMD ($12.41) is significantly undervalued by 37.14% relative to our estimate of its Fair Value price of $19.74 based on Discounted Cash Flow (DCF) modelling, which includes a healthy margin of safety
Significantly Below Fair Value Valuation
TCMD ($12.41) is trading above... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more TCMD due diligence checks available for Premium users.
Valuation
TCMD fair value
Fair Value of TCMD stock based on Discounted Cash Flow (DCF)
Price
$12.41
Fair Value
$19.74
Undervalued by
37.14%
TCMD ($12.41) is undervalued by... subscribe to Premium to read more.
Below Fair Value Valuation
TCMD ($12.41) is significantly undervalued... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
TCMD ($12.41) is trading above... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
TCMD price to earnings (PE)
For valuing profitable companies with steady earnings
Company
19.7x
Industry
31.63x
Market
35.99x
TCMD is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
TCMD is good value based... subscribe to Premium to read more.
P/E vs Market Valuation
TCMD price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
1.42x
Industry
4.01x
TCMD is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
TCMD price to earnings growth (PEG)
For valuing profitable companies with growth potential
TCMD is poor value relative... subscribe to Premium to read more.
PEG Value Valuation
TCMD's financial health
Profit margin
Revenue
$78.9M
Net Income
$3.2M
Profit Margin
4.1%
TCMD's Earnings (EBIT) of $23.60M... subscribe to Premium to read more.
Interest Coverage Financials
TCMD's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$273.0M
Liabilities
$78.1M
Debt to equity
0.4
TCMD's short-term assets ($152.99M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
TCMD's short-term assets ($152.99M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
TCMD's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
TCMD's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$14.8M
Investing
-$397.0k
Financing
-$16.5M
TCMD's operating cash flow ($41.76M)... subscribe to Premium to read more.
Debt Coverage Financials
TCMD vs Medical Device Stocks
Tactile Systems Technology Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.